Editorial |

Is the Use of Topical Antibiotics for Intravitreal Injections the Standard of Care or Are We Better Off Without Antibiotics?

Royce W. S. Chen, MD1; Aleksandra Rachitskaya, MD1; Ingrid U. Scott, MD, MPH2,3; Harry W. Flynn, Jr, MD1
[+] Author Affiliations
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
2Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania
3Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania
JAMA Ophthalmol. 2013;131(7):840-842. doi:10.1001/jamaophthalmol.2013.2524.
Text Size: A A A
Published online


Intravitreal injection of medication is one of the most commonly performed medical procedures in the United States with well over 1 million injections performed annually.1 This number is likely to increase even further because of the aging population as well as the expanding number of indications for intravitreal injections. The most serious complication of intravitreal injection is infectious endophthalmitis, with a reported incidence of 0.02% to 0.1%.2,3 Many patients treated with intravitreal injections receive injections on a monthly basis. Thus, although the risk of endophthalmitis associated with a single injection may be 0.02% to 0.1%, an individual patient’s risk during an entire treatment series may be as high as 1%.4 Although outcomes of infectious endophthalmitis have improved significantly over the past few decades, visual loss can still be severe.5 It is, therefore, imperative that the optimal infection prophylaxis regimen is used with each treatment.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario